For indispensable reporting on the coronavirus crisis, the election, and more, subscribe to the Mother Jones Daily newsletter.

Today brings yet another failure from Donald Trump:

The Trump administration has abandoned a centerpiece of its efforts to address high drug prices, backing away from requiring some discounts to be passed directly to consumers under Medicare that could have lowered their out-of-pocket costs. President Trump had announced the proposal with great fanfare in January as part of the administration’s efforts to deal with the rising costs of prescription drugs, which have fueled public outrage.

Here’s the scorecard:

If I have this right, this is where we stand on drug pricing proposals: Eliminating rebates ❌

International Pricing Index ❓

List prices in advertisements ❌

Reform protected classes in part D ❌

Restricting prices in part D 🆕 — Ben Ippolito (@ben_ippolito) July 11, 2019

The rebate proposal apparently went down in flames because it would have ended up costing some money—about $15-20 billion per year. As we all know, Trump is completely, totally, 100 percent dedicated to helping the forgotten men and women of the country . . . unless it actually costs something. If that’s the case, then you’re on your own, folks.

If it weren’t for the fact that this stuff hurts millions of real-life people, I’d get some mordant amusement out of the fact that Trump repeatedly can’t do even the smallest thing to improve American health care, but continues to tweet out crap about how he wants to eliminate Obamacare entirely because it would be the easiest thing in the world to replace it with something better and cheaper for everyone. Does even his base believe this swaggering rubbish any longer?